EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Unlocking the Mysteries of Rare Disease Drug Development: A Beginner's Guide for Clinical Pharmacologists

Mariam A Ahmed iD, Bilal AbuAsal, Jeffrey S Barrett iD, Karim Azer, Yuen Yi Hon iD, Salwa Albusaysi iD, Elizabeth Shang, Meng Wang, Maria Burian iD, Noha Rayad iD

Clinical and Translational Science · 2025

DOI: 10.1111/cts.70215 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Translational Science, 2025. Verfasst von Mariam A Ahmed und 9 weiteren Autor:innen. Beteiligte Einrichtung: Takeda Pharmaceuticals, Cambridge, MA, USA. Hauptthemen laut MEDLINE: Rare Diseases, Drug Development, Orphan Drug Production, Pharmacology, Clinical. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical pharmacologists face unique challenges when developing drugs for rare diseases. These conditions are characterized by small patient populations, diverse disease progression patterns, and a limited understanding of underlying pathophysiology. This tutorial serves as a comprehensive guide, offering practical insights and strategies to navigate its complexities. In this tutorial, we outline global regulatory incentives and resources available to support rare disease research, describe some considerations for designing a clinical development plan for rare diseases, and we highlight the role of biomarkers, real‐world data, and modeling and simulations to navigate rare disease challenges. By leveraging these tools and understanding regulatory pathways, clinical pharmacologists can significantly contribute to advancing therapeutic options for rare diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rare DiseasesDrug DevelopmentOrphan Drug ProductionPharmacology, ClinicalHumansBiomarkers

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Takeda Pharmaceuticals, Cambridge, MA, USA.
  • Boehringer Ingelheim, Ridgefield, CT, USA.
  • Aridhia Bioinformatics, Glasgow, UK.
  • Novartis, Cambridge, MA, USA.
  • US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.

ORCID-Profile: Mariam A Ahmed, Jeffrey S Barrett, Yuen Yi Hon, Salwa Albusaysi, Maria Burian, Noha Rayad

Zitieren

APA

Ahmed, M. A., AbuAsal, B., Barrett, J. S., Azer, K., Hon, Y. Y., Albusaysi, S., Shang, E., Wang, M., Burian, M., & Rayad, N. (2025). Unlocking the Mysteries of Rare Disease Drug Development: A Beginner's Guide for Clinical Pharmacologists. Clinical and Translational Science. https://doi.org/10.1111/cts.70215

Vancouver

Ahmed MA, AbuAsal B, Barrett JS, Azer K, Hon YY, Albusaysi S, et al. Unlocking the Mysteries of Rare Disease Drug Development: A Beginner's Guide for Clinical Pharmacologists. Clinical and Translational Science. 2025. doi:10.1111/cts.70215

BibTeX
@article{Ahmed2025,
  author = {Ahmed, Mariam A and AbuAsal, Bilal and Barrett, Jeffrey S and Azer, Karim and Hon, Yuen Yi and Albusaysi, Salwa and Shang, Elizabeth and Wang, Meng and Burian, Maria and Rayad, Noha},
  title = {Unlocking the Mysteries of Rare Disease Drug Development: A Beginner's Guide for Clinical Pharmacologists},
  journal = {Clinical and Translational Science},
  year = {2025},
  doi = {10.1111/cts.70215}
}
Kostenlos starten →